Objective: This study aims to discuss the clinical effect of the combined therapy of nifedipine controlledrelease tablets-valsartan on elderly patients who have Type II Diabetic Nephropathy (T2DN) with Hypertension (HTN).
Methods: We recruited 130 elderly patients who have T2DN with HTN and who were admitted to our hospital over the period of April, 2015 to February, 2017. We divided the patients into the control (n=65) and observation groups (n=65) through the odd-even method. The control group received controlledrelease nifedipine tablets and the observation group received controlled-release nifedipine tablets– valsartan. We compared the blood pressure level, total therapeutic efficiency, treatment satisfaction, and BUN level of the two groups.
Results: The blood pressure level of the observation group significantly improved relative to that of the control group (P<0.05). The total therapeutic efficiency of the control group was 80.00%, which was significantly lower than that of the observation group (98.46%) (P<0.05). The treatment satisfaction of the observation group was 96.92%, which was significantly higher than that of the control group (75.38%) (P<0.05). The BUN level of the observation group was considerably higher than that of the control group (P<0.05).
Conclusions: Elderly patients who received controlled-release nifedipine tablets-valsartan for the clinical treatment of T2DN with HTN exhibited significantly improved blood pressure level, total therapeutic efficiency, treatment satisfaction, and BUN levels. Therefore, the reasonable application of controlled-release nifedipine tablets-valsartan therapy can improve the life quality of elderly patients who have T2DN with HTN.Author(s): Xiao-Juan Wang, Jian-Rong Wu, Lin Liu, Qiu Yang, Hui-Lan Yu, Wan-Hong Luo, Zong-Xun Yan